We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
CIRM Awards $5.9 Million to Burnham Institute
News

CIRM Awards $5.9 Million to Burnham Institute

CIRM Awards $5.9 Million to Burnham Institute
News

CIRM Awards $5.9 Million to Burnham Institute

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "CIRM Awards $5.9 Million to Burnham Institute"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The Burnham Institute for Medical Research (Burnham) will receive $5,925,878 in grants awarded from the California Institute for Regenerative Medicine (CIRM) as part of the first research grants approved under Proposition 71, the Stem Cell Research and Cures Act, adopted by California voters in November 2004.

The Independent Citizen's Oversight Committee, the governing body charged with implementing Proposition 71, has approved the allocation of $45 million to fund 72 grants awarded under CIRM's Scientific Excellence through Exploration and Development (SEED) Grant Program.

"In funding these SEED grants, CIRM is fulfilling its commitment to making a major impact on stem cell science and health care," said Dr. Evan Snyder, Professor and Director of Stem Cell Research at Burnham.

"These are the first grants to support fundamental science. By giving priority to SEED funding, CIRM is supporting early-stage science that could not be funded under current stem cell funding guidelines at the National Institutes of Health," Snyder continued.

At Burnham, the SEED funding will help launch projects each of which will explore a different aspect of stem cell biology in areas of medical relevance ranging from heart disease, Parkinson's, cancer, and neural development, to the development of methods for deriving and culturing human embryonic stem cell lines.

Advertisement